利伐沙班属于哪类药,效果好吗？

In recent years, the incidence and harm of atrial fibrillation have continued to increase, bringing a huge economic burden to individuals, families and society. Non-valvular atrial fibrillation is the main cause of ischemic stroke and can increase the risk of stroke 4 to 5 times. Therefore, in the clinical treatment of non-valvular atrial fibrillation, it is very necessary to use reasonable and effective anticoagulant drugs to actively prevent and treat thromboembolism and prevent the risk of stroke. It is a new type of coagulation factor inhibitor, and gender, weight or age have little effect on its drug effect. So, what kind of drug does rivaroxaban belong to, and is it effective?

What kind of drug does rivaroxaban belong to?

Rivaroxaban is a new type of anticoagulant drug. Rivaroxaban has high selectivity for factor Xa. It can competitively inhibit factor Xa, combine with its active site, reduce its activity, interrupt the endogenous and exogenous coagulation cascade, and inhibit thrombin generation and thrombosis. Rivaroxaban can directly inhibit factor Xa without the action of antithrombin III.

Is rivaroxaban effective?

We selected 50 patients with non-valvular atrial fibrillation and adopted group treatment. The control group used general treatment. The experimental group used rivaroxaban treatment, and the staged treatment effects of the two groups of patients were compared and analyzed.

Results: Comparing the treatment conditions and subsequent adverse reactions of the two groups of patients, the conditions of the experimental group were better than those of the control group.

It is concluded that the use of rivaroxaban for anticoagulation treatment in patients with non-valvular atrial fibrillation has a relatively obvious effect and has certain therapeutic advantages. On the basis of good therapeutic effect, the use of rivaroxaban in patients is safer and has certain clinical therapeutic value.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: